Table 3 Long-term outcomes of the women versus men in the propensity score-matched cohorts
Outcome/subgroup | Women | Men | HR/SHR of women (95% CI) | P for interaction |
|---|---|---|---|---|
Primary outcome | Â | Â | Â | Â |
 Cardiovascular death |  |  |  | 0.450 |
  PCI | 1868 (14.3%) | 1899 (14.5%) | 0.99 (0.93–1.05) |  |
  CABG | 343 (20.0%) | 320 (18.6%) | 1.05 (0.90–1.23) |  |
 Acute myocardial infarction (AMI) |  |  |  | 0.080 |
  PCI | 1044 (8.0%) | 1091 (8.4%) | 0.96 (0.88–1.04) |  |
  CABG | 94 (5.5%) | 75 (4.4%) | 1.27 (0.94–1.71) |  |
 Ischemic stroke |  |  |  | 0.157 |
  PCI | 774 (5.9%) | 793 (6.1%) | 0.98 (0.89–1.08) |  |
  CABG | 112 (6.5%) | 137 (8.0%) | 0.81 (0.63–1.04) |  |
 Primary composite outcomea |  |  |  | 0.582 |
  PCI | 3069 (23.5%) | 3168 (24.3%) | 0.97 (0.92–1.02) |  |
  CABG | 457 (26.6%) | 445 (25.9%) | 1.01 (0.88–1.15) |  |
Secondary outcome | Â | Â | Â | Â |
 All-cause mortality |  |  |  | 0.723 |
  PCI | 4752 (36.4%) | 4826 (37.0%) | 0.99 (0.95–1.02) |  |
  CABG | 956 (55.7%) | 968 (56.4%) | 0.97 (0.89–1.06) |  |
 Admission for heart failure |  |  |  | 0.0496 |
  PCI | 1360 (10.4%) | 1048 (8.0%) | 1.32 (1.22–1.43) |  |
  CABG | 244 (14.2%) | 227 (13.2%) | 1.09 (0.91–1.30) |  |
 Revascularization (PCI or CABG) |  |  |  | 0.021 |
  PCI | 3674 (28.1%) | 4232 (32.4%) | 0.84 (0.81–0.88) |  |
  CABG | 151 (8.8%) | 138 (8.0%) | 1.11 (0.88–1.39) |  |
Safety outcome | Â | Â | Â | Â |
 Major bleeding |  |  |  | 0.296 |
  PCI | 350 (2.7%) | 382 (2.9%) | 0.92 (0.79–1.06) |  |
  CABG | 56 (3.3%) | 49 (2.9%) | 1.14 (0.78–1.68) |  |
 GI bleeding |  |  |  | 0.351 |
  PCI | 1944 (14.9%) | 2034 (15.6%) | 0.95 (0.90–1.01) |  |
  CABG | 263 (15.3%) | 255 (14.9%) | 1.04 (0.88–1.23) |  |
 Intracranial hemorrhage |  |  |  | 0.738 |
  PCI | 85 (0.7%) | 104 (0.8%) | 0.82 (0.62–1.09) |  |
  CABG | 13 (0.8%) | 18 (1.0%) | 0.72 (0.35–1.47) |  |